Vivani Medical Mergers and Acquisitions Presentation Deck
Vivani Executive Leadership Team
Adam Mendelsohn PhD - CEO/Director
. Co-founder/Co-inventor of Nano Precision Medical technology
PhD Bioengineering (UCSF/UC Berkeley)
Management of Technology Certificate at Haas School of Business
Research focused on diabetes treatment
Formerly at Boston Scientific and Minimed
Truc Le, MBA - Chief Operations Officer
• Numerous COO and Executive Positions at Device and Drug-
Device Companies, including:
COO at Dance Biopharm, COO at Avid Bio
Exec VP at Prima Biomed, Sr. VP at Nektar Therapeutics
(responsible for Exubera approval), and Worldwide VP at
Johnson & Johnson
Lisa Porter, MD - Chief Medical Officer
• Former Chief Medical Officer for Eiger BioPharmaceuticals
and Dance BioPharm
• Former VP of Medical Development for Amylin
• Former Director at GSK, Global Head of Clinical Strategy for
Avandia
• Former Board member of ViaCyte, Inc.
Brigid Makes MBA - Chief Financial Officer
. Former Sr. VP and CFO Miramar Labs
• Former Sr. VP and CFO AGA Medical
• Former CFO Nektar Therapeutics, Oravax and Haemonetics
. Current Board director: Quantun-Si, Aziyo and Mind Medicine
• Involved in/Directed 2 IPOs, 2 reverse mergers and 1 SPAC
Don Dwyer, MBA - Chief Business Officer
• Former Executive Director at AstraZeneca with
leadership roles in drug development, commercial and
business development
• Former NPM Board observer for AZ
• Former PhaseBio Board observer for AZ (prior to IPO)
• Former Director at Cephalon and Rhone Poulenc Rorer
3View entire presentation